Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/3/2022 | Market Perform → Underperform | Raymond James |
15-12G - Valens Company, Inc. (0001859902) (Filer)
F-10POS - Valens Company, Inc. (0001859902) (Filer)
6-K - Valens Company, Inc. (0001859902) (Filer)
KELOWNA, BC, May 16, 2022 /PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS)) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of branded cannabis products, today announced that it has separated the roles of Chair and Chief Executive Officer (CEO) and appointed Andrew Cockwell as its new Chair of the Board, effective immediately. This decision follows the Company's recent Nasdaq listing and its commitment to governance best practices including transparency and accountability. Tyler Robson has stepped down as Chair in full support of this decision and will remain on the Board and as the CEO of the Company.
SNDL Inc. (NASDAQ:SNDL) completed the previously disclosed acquisition of all of the issued and outstanding common shares of The Valens Company Inc. (NASDAQ:VLNS) (TSX:VLNS), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act, for total consideration of approximately CA$138 million ($103 million) consisting of common shares of SNDL and assumption of Valens' CA$60 million non-revolving term loan facility. With approximately CA$262.5 million in net cash and no debt, SNDL will continue to have one of the strongest balance sheets in the North American cannabis industry. The combined company will operate as SNDL Inc.,
The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS), announced that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement with SNDL Inc. (NASDAQ:SNDL) under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the arrangement, Valens' shareholders will receive, for each common share of Valens, 0.3334 of a common share of SNDL. Based on the closing price of the SNDL shares on the Nasdaq Capital Market as at August 19, 2022, the consideration represents an implied value of CA$1.26 per Valens S
The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce today that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement (the "Arrangement") with SNDL Inc. ("SNDL") under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the Arrangement, Valens' shareholders will receive, for each common share of Valens (each, a "Valens Share"), 0.3334 of a common share of SNDL (the "Offer Exchange Ratio")
Creates a low-cost vertically integrated Canadian company generating over a billion dollars in annualized pro forma revenue1 CALGARY, AB, Jan. 17, 2023 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" the "Company") is pleased to announce the completion of the previously disclosed acquisition of all of the issued and outstanding common shares ("Valens Shares") of The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("Valens"), other than those held by SNDL and its subsidiaries, pursuant to a plan of arrangement under the Canada Business Corporations Act (the "Transaction"), for tota
KELOWNA, BC, Jan. 3, 2023 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce today that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement (the "Arrangement") with SNDL Inc. ("SNDL") under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August 22, 2022. Under the terms of the Arrangement
KELOWNA, BC, Dec. 13, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced today it received an extension of 180 calendar days from the Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the "Bid Price Requirement"), following the expiration of the initial 180 calendar days period to regain compliance on December 12, 2022. The Nasdaq determination is based on the Company meeting the continued listing requirement for mar
Raymond James downgraded Valens Co from Market Perform to Underperform
HOD HASHARON, Israel,, July 20, 2022 /PRNewswire/ -- Valens Semiconductor (NYSE:VLN), a premier provider of high-speed connectivity solutions for the audio-video and automotive markets, today announced that it will release its second quarter 2022 financial results before the market opens on Wednesday, August 10, 2022. In conjunction with this announcement, Valens will host a conference call on Wednesday, August 10, 2022, at 8:30 a.m. Eastern Time (ET) to discuss its second quarter 2022 financial results and business outlook. To access this call, dial +1 (888) 642-5032 (U.S.), 0 (800) 917-5108 (UK), 03 918 0609 (Israel) or +972 3 918 0609 (all other locations). A live webcast of the conferenc
Realized initial benefits of Integration Initiatives, with SG&A as a percent of revenue declining 908 basis points in Q2 2022 from Q1 2022 In five months, Valens has actioned $15 million in annual cost savings and has identified in excess of $5 million additional cost savings to be actioned over the next few quarters exceeding management's original $20 million target Achieved double-digit revenue growth in Green Roads, B2B, & International revenue segments. Provincial sales rebounded strongly in June with record monthly revenue Top 10 licensed producer in Canada, with a 3.2% market share for three months ending May 2022 Valens reiterates its objective of achieving positive adjusted EBITDA(2
KELOWNA, BC, July 6, 2022 /PRNewswire/ - The Valens Company Inc. (TSX:VLNS) (NASDAQ:VLNS) (the "Company" "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce it will issue its second quarter 2022 financial results for the period ended May 31, 2022, on Wednesday, July 13, 2022, after market close. CONFERENCE CALL DETAILS The Company will host a conference call the following day, Thursday, July 14, 2022, at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time to discuss the financial results and business outlook. Participant Dial-In